TECFIDERA® and TYSABRI® Data Demonstrate Improved Outcomes with Early MS Treatment
Go back to TECFIDERA® and TYSABRI® Data Demonstrate Improved Outcomes with Early MS Treatment| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 221.56 +9.01 (4.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $212.55 | 52 Week High | $333.65 | |||
| Open | $215.33 | 52 Week Low | $223.02 | |||
| Day High | $222.15 | P/E | 28.37 | |||
| Day Low | $215.08 | EPS | $7.81 | |||
| Volume | 886,912 | |||||
| (NASDAQ: BIIBV) | Delayed: 259.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.61 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $259.61 | P/E | N/A | |||
| Day Low | $259.61 | EPS | $ | |||
| Volume | 19,000 | |||||
